Keiretsu Forum London – final investor meeting of 2025!
✨ Join us for the final Keiretsu Forum London investor meeting of 2025!
We’re closing out 2025 with a strong, diverse lineup of Founders featuring two Keiretsu Forum portfolio companies, both with completed due diligence reports, alongside two exciting UK-based ventures. This is a fantastic opportunity for our investor community to support high-quality innovation and help us finish the year on a high.🎤 Presenting Companies: 🔹 Solaris Endovascular – Randy Hubbell, CEO A Keiretsu Forum portfolio company developing next-generation vascular intervention technology, supported by a comprehensive due diligence report. 🔹 Evil Genius Games – David T. Scott, CEO Another portfolio company with completed K4 diligence, building a fast-expanding entertainment and gaming franchise with major licensing opportunities. 🔹 Lutra Health – Charles Solanki, CEO & Co-founder A UK-based digital health company improving patient experience and operational efficiency across care pathways. 🔹 Anathem – Richard Apletree, CEO Innovators in behavioural science and workforce performance, providing measurable insights to help organisations understand and strengthen their teams.As we wrap up the year, we’re proud of the founders we’ve supported, the capital deployed, and the momentum building across our global network. We hope you’ll join us as we round out 2025 with another strong session of curated deal flow.🔗 Register to attend: https://lnkd.in/e2SWGRjA
🔹 Solaris Endovascular – Randy Hubbell, CEO
A Keiretsu Forum portfolio company developing next-generation vascular intervention technology, supported by a comprehensive due diligence report.
🔹 Evil Genius Games – David T. Scott, CEO
Another portfolio company with completed K4 diligence, building a fast-expanding entertainment and gaming franchise with major licensing opportunities.
🔹 Lutra Health – Charles Solanki, CEO & Co-founder
A UK-based digital health company improving patient experience and operational efficiency across care pathways.
🔹 Anathem – Richard Apletree, CEO
Innovators in behavioural science and workforce performance, providing measurable insights to help organisations understand and strengthen their teams.As we wrap up the year, we’re proud of the founders we’ve supported, the capital deployed, and the momentum building across our global network. We hope you’ll join us as we round out 2025 with another strong session of curated deal flow.🔗 Register to attend: https://lnkd.in/e2SWGRjA